IvelinRadkov/iStock via Getty Images
Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy.
After one year of continuous treatment, participants showed not only a halt in disease progression, but also measurable improvements compared to their
Delhi: With the Budget around the corner, market veteran Madhusudan Kela expressed confidence that fiscal discipline will continue, while highlighting...
As any local shop owner will tell you, running a brick-and-mortar business in the age of Amazon is an uphill...
As India prepares for the Union Budget 2026, economists and market experts are weighing in on the country’s macroeconomic performance...
The Knesset has approved the first reading of the 2026 budget by 62 votes to 55. Now, the various...
Tesla CEO Elon Musk kicked off the new year by springing several eye-popping surprises on shareholders, including a $2 billion...
Gold surged for a ninth straight day, breaking above $5,550 as rising geopolitical tensions and expectations of Federal Reserve easing...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
